Leucine-Rich Alpha-2-Glycoprotein (LRG-1) as a Potential Kidney Injury Marker in Kidney Transplant Recipients

Anna Popova; Aiga Vasiļvolfa; Kārlis Rācenis; Renārs Erts; Baiba Šlisere; Anna Jana Saulīte; Ieva Ziedina; Inese Folkmane; Harijs Čerņevskis; Juta Kroiča; Aivars Pētersons; Viktorija Kuzema

doi:10.12659/AOT.936751

06 September 2022 : Original article

Leucine-Rich Alpha-2-Glycoprotein (LRG-1) as a Potential Kidney Injury Marker in Kidney Transplant Recipients

Anna Popova^123ACDE*, Aiga Vasiļvolfa^134ABCDEF, Kārlis Rācenis^12ACD, Renārs Erts^5C, Baiba Šlisere^2BC, Anna Jana Saulīte^12EF, Ieva Ziedina

^14AB, Inese Folkmane^13AB, Harijs Čerņevskis^14DE, Juta Kroiča^2ACDF, Aivars Pētersons^14ACD, Viktorija Kuzema

^14ACDE

DOI: 10.12659/AOT.936751

Ann Transplant 2022; 27:e936751

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Linear regression analysis between serum and urine LRG-1. Every 1 ug/ml increase in urine LRG-1 was associated with a 53-units increase in serum LRG-1. Linear regression accounted for R2=25% of the variance of the serum LRG-1. Created using R-Studio (version 3.6.0, R Foundation for Statistical Computing, Vienna, Austria).

Back to the Article

Leucine-Rich Alpha-2-Glycoprotein (LRG-1) as a Potential Kidney Injury Marker in Kidney Transplant Recipients

Your Privacy